Phase 3 trials suggest ways to improve current hematologic cancer therapies
- PMID: 18252877
- DOI: 10.1001/jama.299.5.510
Phase 3 trials suggest ways to improve current hematologic cancer therapies
Comment in
-
Radiopharmaceutical reimbursement rates.JAMA. 2008 Jun 4;299(21):2512; author reply 2512-3. doi: 10.1001/jama.299.21.2512-c. JAMA. 2008. PMID: 18523217 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
